Acquisition of mesenchymal-like phenotypes and overproduction of angiogenic factors in lenvatinib-resistant hepatocellular carcinoma cells-Reference-Cited by-同舟云学术

Acquisition of mesenchymal-like phenotypes and overproduction of angiogenic factors in lenvatinib-resistant hepatocellular carcinoma cells

Published:2021-04 Issue: Volume:549 Page:171-178
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Ao Junjie,Chiba Tetsuhiro^ORCID,Shibata Shuhei,Kurosugi Akane,Qiang Na,Ma Yaojia,Kan Motoyasu,Iwanaga Terunao,Sakuma Takafumi,Kanzaki Hiroaki,Kanayama Kengo,Kojima Ryuta^ORCID,Kusakabe Yuko,Nakamura Masato,Saito Tomoko,Nakagawa Ryo,Kondo Takayuki^ORCID,Ogasawara Sadahisa,Suzuki Eiichiro,Muroyama Ryosuke,Kato Jun,Mimura Naoya,Kanda Tatsuo^ORCID,Maruyama Hitoshi,Kato Naoya

Funder

AMED

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference40 articles.

1. Review of hepatocellular carcinoma: epidemiology, etiology, and carcinogenesis;Ghouri;J. Carcinog.,2017

2. Hepatocellular carcinoma: a review;Balogh;J. Hepatocell. Carcinoma,2016

3. DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: real-world experience from HCV-TARGET cohort;Verna;J. Hepatol.,2020

4. The impact of the revolution in hepatitis C treatment on hepatocellular carcinoma;Wirth;Ann. Oncol.,2016

5. Current treatment landscape for advanced hepatocellular carcinoma: patient outcomes and the impact on quality of life;Li;Cancers,2019

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reserpine, a novel N6-methyladenosine regulator, reverses Lenvatinib resistance in hepatocellular carcinoma;Phytomedicine;2024-09

2. Metabolic reprogramming driven by METTL1-mediated tRNA m7G modification promotes acquired anlotinib resistance in oral squamous cell carcinoma;Translational Research;2024-06

3. Lenvatinib‐resistant hepatocellular carcinoma promotes malignant potential of tumor‐associated macrophages via exosomal miR‐301a‐3p;Annals of Gastroenterological Surgery;2024-05-13

4. Lenvatinib in hepatocellular carcinoma: Resistance mechanisms and strategies for improved efficacy;Liver International;2024-05-03

5. Research progress on the structure, function, and use of angiogenin in malignant tumours;Heliyon;2024-05